Related Experiment Video
Updated: Dec 17, 2025
Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation
Published on: July 23, 2012
Analysis of MicroRNA-18a Expression in Multiple Sclerosis Patients
Atefeh Sohan Forooshan Moghadam1, Mitra Ataei2, Ghazaleh Arabzadeh1
1Department of Biology, Nourdanesh Institute of Higher Education, Meymeh, Isfahan, Iran.
Background:
In multiple sclerosis (MS), the immune system acts against myelin lesions of the central nervous system, destroying neuronal fibers resulting in signal transmission disturbances in the nervous system. MicroRNAs play important roles in the post-transcriptional regulation of gene expression and in the regulation of disease activity and its response to treatment. The goal of this study was to determine the role of miR-18a-5p by comparing its expression in MS patients and healthy subjects.
Methods:
RNA was isolated from blood samples of 32 MS patients and 32 healthy individuals, and miR-18a-5p expression was determined by real-time polymerase chain reaction (real-time PCR).
Results:
miR-18a-5p expression was significantly less in MS patients than in healthy subjects.
Conclusion:
The reduction of miR-18a-5p expression may be via pathway signaling. Altered signaling plays an important role in MS pathogenesis and the miR-18a-5p expression profile in blood cells can be described as a prognostic biomarker and identifier of high-risk individuals in MS.
Insights
MicroRNA-18a-5p (miR-18a-5p) levels are lower in multiple sclerosis (MS) patients compared to healthy individuals. This finding suggests miR-18a-5p may serve as a biomarker for MS risk.
Area of Science:
- Neuroimmunology
- Molecular Biology
- Biomarker Discovery
Background:
- Multiple sclerosis (MS) involves immune system attack on central nervous system myelin.
- MicroRNAs regulate gene expression and disease activity in MS.
- Investigating specific microRNAs like miR-18a-5p is crucial for understanding MS.
Purpose of the Study:
- To compare miR-18a-5p expression levels in multiple sclerosis patients versus healthy controls.
- To elucidate the potential role of miR-18a-5p in MS pathogenesis.
Main Methods:
- RNA extraction from blood samples of 32 MS patients and 32 healthy controls.
- Quantification of miR-18a-5p expression using real-time polymerase chain reaction (real-time PCR).
Main Results:
- Significantly reduced expression of miR-18a-5p was observed in MS patients compared to healthy subjects.
- This downregulation indicates a potential link between miR-18a-5p levels and MS.
Conclusions:
- Reduced miR-18a-5p expression may be linked to altered signaling pathways in MS.
- miR-18a-5p in blood cells shows potential as a prognostic biomarker for identifying high-risk individuals with MS.
Related Concept Videos
01:22MicroRNAs
01:22MicroRNAs